chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 30-60 minutes after administration of vaccine, patient began experiencing whelps and swelling of the right arm as well as numbness and tingling.  Benadryl 50mg PO given.  Symptoms worsened.  Began feeling numbness to tongue..  Heart rate elevated at 118.  Patient sent to emergency department for further evaluation and received epinephrine and solumedrol.  Discharged home approximately 4 hours later.
Initial and follow up information has been received from a Medical Assistant concerning a 62 year old female patient who on 11-MAR-2008 was vaccinated IM in to right arm with a dose of pneumococcal 23v polysaccharide vaccine, lot # 655765/1229F. The MA reported that a nurse might have given the patient 0.5 mL of pneumococcal 23v polysaccharide vaccine or 1.5 mL of pneumococcal 23v polysaccharide vaccine at one visit. There were three doses remaining in the multi-dose vial prior to the administration but was discarded in the sharp container after the injection was administered. It was stated that patient's pneumococcal 23v polysaccharide vaccine record was not clear. No adverse event reported. No other details available. The patient's outcome was unknown.  Additional information is not expected.
1/19/2022 that night I woke up in the middle of the night with a really bad headache. When I woke up, I had a sore throat in addition to the headache. The day before I had noticed drainage, but felt it was just from traveling. I tested for COVID on 1/20/2022 and it was negative. On 1/22/2022 I still did not feel better and felt I could not travel again not feeling well. I tested for COVID again and it was positive. I drove home on 1/23/2022. I developed a cough which was not bad. The headache was gone. I noticed my vision was horrible, unsteady and I could not read anything. The television bothered me to watch. I had to start using reading glasses. I was tired until the third week of February. The vision thing remained. I found out I have a cyst behind my retina behind my right eye and will require surgery. It took two weeks to test negative again. The only lasting thing from having COVID, is my eye problem.
Information has been received from a physician concerning a 12 year old female with a penicillin allergy and latex allergy who on 03-JAN-2007 was vaccinated intramuscularly with a 0.5 mL first dose of GARDASIL. Concomitant therapy included Concerta. Later that evening, on 03-JAN-2007, the patient developed nausea and vomited once. At approximately 07:00 am on 04-JAN-2007, the patient developed a headache and temporal blindness that lasted approximately 40 seconds. The patient was taken to the emergency room. At 10:03 am, the patient had a second incidence of headache and temporal blindness that also lasted approximately 40 seconds. At the time of this reported, the patient was stable but was to be admitted to the hospital for observation. At the time of this report, the outcome was unknown. Additional information has been requested. 01/22/07-records received and reviewed from Medical Center for DOS 01/0407-transferred with DX of new onset seizures to another Hospital. Records requested. CT brain without contrast: negative exam, recommend MRI.  01/30/07-rcords received for DOS 01/04-01/05/07 DC DX: 1. Vasovagal response secondary to dehydration 2. Syncope secondary to #1. Hospital Course: Transferred from Med Ctr. Admitted with vomiting decreased oral intake since yesterday, complained of blindness and severe headaches this morning with fever of 101.4. Experienced 35-45 second of complaining of blindness, loss of consciousness and staring episode at Med Ctr.  PMH: Status post Kawasaki disease two weeks after developing chicken pox, attention deficit/hyperactivity disorder.
COVID-19 confirmed by positive COVID-19 test; Covid-19 Positive; This is a spontaneous report from a contactable other HCP (Nurse). A 50-year-old male patient received bnt162b2 (BNT162B2 Formulation; Solution for injection), dose 2 intramuscularly, administered in Arm Left on 05Feb2021 07:00 (Batch/Lot Number: EL3248) as DOSE 2, SINGLE (at the age of 49-year-old) for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was unknown if patient had covid prior vaccination. Historical vaccine included received first dose of bnt162b2 intramuscularly administered in Arm Left on 15Jan2021 07:00 (Batch/Lot Number: EL3248) as DOSE 1, SINGLE (at the age of 49-year-old) for COVID-19 immunisation. It was unknown if the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Aug2021, the patient had fever, congestion and coughing. The patient underwent lab tests and procedures which included Nasal Swab which was positive on 24Aug2021 (COVID positive post vaccination). The patient visited physician office due to the event. It was unknown if patient received treatment for event or not. The outcome of the events reported as recovering.   No follow-up attempts needed. No further information expected.; Sender's Comments: Based on the known safety profile of the vaccine BNT162B2, a temporal relation between the events (Vaccination Failure, Covid-19) and the administration of the vaccine cannot be excluded.
Got H1N1 mist03/03/10. Allergic hives arms/cheeks 03/07/10. Vomited x2 03/07/10.
Got a flu shot injection at Hospital yesterday around 2 pm. Woke 6am today with nausea, vomiting and severe weakness,chills.
Patient fainted and fell on the ground about 10 minutes after the vaccine was administered. We called the ambulance and they came 10 minutes later and checked his vitals. Patient did not leave on the ambulance.
1st dose administered 16-Jun-2021 (beyond 30-day mark after being refrigerated); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1st dose administered 16-Jun-2021 (beyond 30-day mark after being refrigerated)) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic hepatitis C (Started treatment with Harvoni x 12 weeks on 18/Aug/2021) since 2021, Hypertension since 22-Apr-2021, Osteoarthritis since 22-Apr-2021, Major depression since 18-Jan-2018 and CVA (History of CVA). Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] from 19-Nov-2020 to an unknown date for CVA, LEDIPASVIR, SOFOSBUVIR (HARVONI) from 18-Aug-2021 to an unknown date for Chronic hepatitis C, AMLODIPINE from 22-Apr-2021 to an unknown date for Hypertension, QUETIAPINE from 19-Jan-2021 to an unknown date for Major depression, NAPROXEN from 19-Feb-2021 to an unknown date for Osteoarthritis.    On 16-Jun-2021 at 1:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (1st dose administered 16-Jun-2021 (beyond 30-day mark after being refrigerated)). On 16-Jun-2021, EXPIRED PRODUCT ADMINISTERED (1st dose administered 16-Jun-2021 (beyond 30-day mark after being refrigerated)) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  The Moderna vaccine was stored in the refrigerator on 20-Apr-2021.  No adverse events reported by patient.   This case was linked to MOD-2021-369042 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Nov-2021: No new information.
Immediately after vaccination, patient followed father both were walking around the store.  After a few minutes the patient fell to his knees then slouched onto the floor.  The Father said he appeared unconscious.  When rubbing his chest, the patient became conscious again and said he felt dizzy.  Patient was put on a chair and looked pale and then the pharmacy was notified.
Pt was given Hi-Dose Flu vaccine by mistake. Should have been given quadrivalent vaccine instead.
Within 10-15 minutes patient notes his throat began to feel 'scratchy' and felt as if his throat was swelling. Did not experience respiratory distress. Presented to the emergency department where he was treated for allergic reaction. Was sent home with symptomatic care and due to an exacerbation of his symptoms a few days later he presented for re-evaluation.
Received Shingle shot November 2017, 2 weeks after I started to have huge floaters and flashes in my eyes and also its not described as a pain more of a nuisance because you can feel your eye balls in your head , didn't have that before . Diagnosed with a partially detached retina right eye, macula puffer in left eye which neither were detected in previous eye exams .  Condition has stabilized,  but still have huge floaters, eye irritation,  diminished vision day and night
Nausea/Vomiting, Nerve pain  Sore arm, headache  Cried
This case was reported by a lawyer and described the occurrence of loss of concentration in a 17 year old female pt who received lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced fatigue, migraine headaches, myalgias, arthralgias, dizziness, gait disturbances, insomnia, numbness, loss of concentration, cognitive problems and fibromyalgia type symptoms with a SPECT (single photon emission computerized tomography) scan showing focally diminished cortical brain activity. Time to onset, treatment, and outcome were not reported.
Severe headache lasting 7 days.  Pain/Ache at base of the skull.  Diarrhea x 4 days.  Fatigue.
Client ate milk and 2 slices of bread for breakfast.  Came to school, received nasal vaccination with other class members waited 15 min, then went to physical education class.  Played soccer.  Came back to media Ctr where us and observation started VS @ 1201 BP 116/78 HR88.  Very diaphoretic and syncopal.  Had dropped beat every 15-20 beats.  Lips blue and dry.  EMS called, mom arrived and took child home - EMS then left with client.
This spontaneous report as received from the patient's mother referring to a not pregnant 18 year old female patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 21-SEP-2017 the patient was vaccinated with the second dose of GARDASIL 9 intramuscularly for prophylaxis (lot number and expiration date were not reported). On an unspecified date in September 2017, reported as almost immediately after receiving the 2nd dose of GARDASIL 9 the patient experienced extreme fatigue and difficulty getting out of bed. It was reported that the patient did not seek medical attention neither received treatment to the aformentioned events. On 14-NOV-2017, the patient symptoms fatigue and difficulty getting out of bed were still not resolved. Additionally, the reporter did not provide causality assessment between the events and vaccination with GARDASIL 9.
Bell's palsy; fever; Diarrhea; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2 reported as Covid Vaccine), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter stated that "after I got the Covid vaccine after two day I mean after the same day like I got it I came home and I had fever for two days actually and then I have the next day diarrhea, two days and then again I experienced some fever after I experienced some Bell's palsy so my question is if I am going to take the Covid vaccine again should I take it or if I would not take it do I have the protection? So, I have this concern because I experienced Bell's palsy." The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Intense erythema with warmth at injection site with streaking accompanied by systemic symptoms, fever, malaise. Symptoms improved quickly after starting antibiotics implicating infection. Similar events in Zofran patients
Itchiness to left arm for a minute then went away. Same thing to right wrist then went away.
Severe Headache on February 5th and nausea, headache, and the feeling that I would faint if I stood on the 6th.  I checked my BP and it was 128/70.  My blood sugar was 80.  The symptoms passed by the 7th of February (my 80th birthday).
fever, chills, muscle soreness, sinus congestion, nausea, headache, myalgia, injection site pain
First injection: mild reactions with no heart involvement. Second injection: Heart A-Fib lasting for 13 hours with very rapid and erratic heart beat ranging from 105 to 151 bpm. Completely resolved by itself and heart rate returned to my normal 75 bpm as measured on my finger-tip pulse oximeter. This type of event has not occurred since my A-Fib ablation done 7 years ago.  Also experienced, fever, aches, sore arm, night sweats within first 12 hours and diarrhea 48 hours after injection.
Pt came into office w/ 1 day H/o fever essential w/ maculopapular rash in the torso and extremities. Tmax 100.5 degrees F (plus) fussiness - no vom/diarrhea - good appetite and urine output - No known sick contacts. Pt given TYLENOL 160 mg/5 ml (4-5 ml q 6 hrs); MOTRIN 100 mg/5 ml (5ml q 6-8 hrs prn).
I have developed severe plaque psoriasis after getting these shots, I hadn?t been vaccinated in a while & I never had this issue before.
Noticed redness, soreness and swelling at injection site less than 24 hrs after receiving vaccine. Warm and tender to touch. Localized rxn. No changes in LOC. No SOB/resp distress. No rash noted.
Post vax, by 11:00 pm on 12/21/2000, the patient experienced projectile vomiting, abdominal cramps, nausea and had no appetite. Unspecified medical attention was sought. The patient's outcome was unknown. Additional information has been requested.
was admitted on 12/8/2021 because of sharp chest pain.  It was associated with shortness of breath.  She tested positive for COVID-19 on 12/3. She was started on monoclonal antibody infusion.  On the day of admission she became more short of breath and developed sharp chest pain.  She also had significantly decreased appetite and also had decreased fluid intake.  On arrival in the emergency room she had a temperature of a 100°.  She was dyspneic with ambulation and her oxygen saturation dropped to 88% on room air.  CTA of the chest was ordered and this is showed no evidence of pulmonary embolism.  There is interval developing ground-glass opacities on the right at along with extensive consolidation in the right lower lobe concerning for bacterial pneumonia.  She was given IV Decadron.  She is having a cough.  She is on nasal cannula oxygen.  She says that she has been able to eat.   She was able to weaned off oxygen and oxygen saturation was done but she did not drop below 92%. She received Remdesivir and Decadron during the hospital stay. She was also treated with Rocephin and Azithromycin. Antibiotics were completed during her hospital stay. She was stable for discharge to home.
felt like he was having a seizure; arms were failing,were going in all directions; fever of 102.3 degrees; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (felt like he was having a seizure) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced SEIZURE (felt like he was having a seizure) (seriousness criterion medically significant), DYSKINESIA (arms were failing,were going in all directions) and PYREXIA (fever of 102.3 degrees). The patient was treated with TEMAZEPAM for Adverse event, at an unspecified dose and frequency. On 14-Apr-2021, SEIZURE (felt like he was having a seizure), DYSKINESIA (arms were failing,were going in all directions) and PYREXIA (fever of 102.3 degrees) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 102.3 (High) 102.3 degrees.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provide  Consumer mentioned he thought he was having a stroke because he has had one. The Patient went to the hospital but was not hospitalized for prolonged period or overnight.  Company comment: This case concerns a 69-year-old, male patient with a history of stroke, who experienced the unexpected serious AESI event of seizure, with concurrent non-serious events of movement abnormal and pyrexia. The events occurred approximately on the same day after the second dose of mRNA-1273 vaccine. The patient was treated with TEMAZEPAM. The rechallenge was not applicable since the events happened after the second dose and no information on additional dosing is available. The medical history of stroke and concurrent event pyrexia remain as confounders. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Case was assessed as serious due to important medical event and medical judgement.; Sender's Comments: This case concerns a 69-year-old, male patient with a history of stroke, who experienced the unexpected serious AESI event of seizure, with concurrent non-serious events of movement abnormal and pyrexia. The events occurred approximately on the same day after the second dose of mRNA-1273 vaccine. The patient was treated with TEMAZEPAM. The rechallenge was not applicable since the events happened after the second dose and no information on additional dosing is available. The medical history of stroke and concurrent event pyrexia remain as confounders. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Case was assessed as serious due to important medical event and medical judgement.
i have a allergy to the vaccine.; hot burning rash.; hot burning rash.; itching; This case was reported by a consumer via interactive digital media and described the occurrence of allergy to vaccine in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included chickenpox (was born with chickenpox).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than a day after receiving Shingles vaccine, the patient experienced allergy to vaccine, rash, burning sensation and pruritus. On an unknown date, the outcome of the allergy to vaccine, rash, burning sensation and pruritus were not recovered/not resolved.   The reporter considered the allergy to vaccine to be possibly related to Shingles vaccine. It was unknown if the reporter considered the rash, burning sensation and pruritus to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the consumer for herself/himself. The age at vaccination was not reported. The reporter stated that, he/she got the first dose of Shingles vaccine and woke up in the middle of the night with a hot burning rash, it's  been 3 months and the patient still itching.  The patient thought he/she have a allergy to the vaccine.
I started having noticeable pain the day after I received my fourth dose. The pain got progressively worse. This continued for about three weeks. I went to the doctor. The finding was that I had a torn rotator cuff in my shoulder.
It was reported in published articles, titles as stated above that a 34 year old female phlebotomist, with a history of smoking and no other co existing conditions, who at 12 months of age was vaccianted with a dose of MMR II. It was reported that the pt experienced vaccine failure and was hospitalized for severe measles. Serum drawn four days after the onset of the rash was positive for anti measles IgM and IgG, Her direct source of exposure could not be identified, but she worked at the hospital where two measles pts had been treated. It was noted that it could not determined whether the case represented a primary vaccine failure ( a failure of the vaccine to induce immunity) or a secondary vaccine failure (the result of wandering immunity). It was noted that the severity of the case suggested the former, since secondary vaccine failures tended to produce mild disease. It was reported that the pt required six days of ventilator support for pneumonia complicated by the acute respiratory distress syndrome. Additional information has been requested.
Knee swelling/My knees swelled significantly; Patient had such extreme symptions and pain.; My hands were swollen to the point that I was unable to dress; Diminished my mobility; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Knee swelling/My knees swelled significantly), PAIN IN EXTREMITY (Patient had such extreme symptions and pain.), PERIPHERAL SWELLING (My hands were swollen to the point that I was unable to dress) and MOBILITY DECREASED (Diminished my mobility) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Still's disease adult onset (Significant swelling, pain that patient never experienced prior to Moderna) since August 2000.    On 19-Feb-2021 at 1:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced JOINT SWELLING (Knee swelling/My knees swelled significantly), PAIN IN EXTREMITY (Patient had such extreme symptions and pain.), PERIPHERAL SWELLING (My hands were swollen to the point that I was unable to dress) and MOBILITY DECREASED (Diminished my mobility). The patient was treated with PREDNISONE ongoing from June 2021 for Swelling and Pain, at a dose of 60-mg-5mg. At the time of the report, JOINT SWELLING (Knee swelling/My knees swelled significantly), PAIN IN EXTREMITY (Patient had such extreme symptions and pain.), PERIPHERAL SWELLING (My hands were swollen to the point that I was unable to dress) and MOBILITY DECREASED (Diminished my mobility) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, C-reactive protein: 189 C-Reactive Protein- 189. On an unknown date, Red blood cell sedimentation rate: 80 SED rate was 80. On an unknown date, White blood cell count: 17.2 WBC -17.2.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient was unable to make a twisting movement such as to remove a water bottle lid and patient had to hold their coffee cup with 2 hands. Patient started Prednisone after receiving Moderna. The patient had never experienced such intense pain, swelling. No concomitant medications was provided by the reporter.   This case was linked to MOD-2022-510038, MOD-2022-452278 (Patient Link).
The pt received the vaccine on 10/16/1995. Developed chicken pox on 04/05/2002.